Bruce D. Cheson, MD, FACP, FAAAS, FASCO
Bruce D. Cheson, MD, FACP, FAAAS, FASCO, is a world-renowned expert in lymphoma and chronic lymphocytic leukemia (CLL) and one of the international leaders in the field for decades. He served as head of hematology at MedStar Georgetown University Hospital’s Lombardi Comprehensive Cancer Center from 2002 to 2020. With more than 40 years of experience in academics, Dr. Cheson’s primary focus is on lymphoid malignancies.
He is a scientific advisor to the Lymphoma Foundation and sits on numerous scientific boards for both the non-profit and biotech sectors. Additionally, he serves as an advisor to clinical trials monitoring for molecular and genetic companies.
Dr. Cheson possesses extensive experience in protocol and drug development processes, having collaborated with the National Cancer Institute for over a decade. He has authored over 400 articles and has more than 30 years of experience in designing and conducting clinical trials and drug development in hematologic malignancies, particularly lymphomas and CLL.
Dr. Cheson earned his medical degree from Tufts University School of Medicine. He completed his residency in internal medicine at the University of Virginia Hospital and his clinical and research fellowship at New England Medical Center Hospital. He is Board-certified in hematology and internal medicine.
Dr. Cheson is seeing patients at the Bethesda clinic of The Center for Cancer and Blood Disorders, which is located at 6410 Rockledge Drive, Suite 660.